对内皮蛋白C受体和整体蛋白αvβ6的自身抗体预测了性结肠炎的发展
Motoi Sawahashi1, Yoichi Kakuta2, Takeo Naito1
1Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1, Seiryo, Aoba-Ku, Sendai, Miyagi, 980-8574, Japan.
现在可以预测性结肠炎 (UC) 的发生. 血清自身抗体,特别是抗内皮蛋白C受体 (anti-EPCR) 和抗整体素αvβ6 (anti-αvβ6),显示出UC发展的强大预测能力.
科学领域:
- 胃肠道学和免疫学
- 生物标志物发现发现
- 预测医学是一种预测医学.
背景情况:
- 缺少关于性结肠炎 (UC) 发病的预测方法.
- 血清自身抗体是早期UC检测的潜在生物标志物.
- 这项研究旨在验证UC发育的血清学和环境风险因素.
研究的目的:
- 验证用于预测UC发病的血清学和环境因素.
- 使用已识别的因素构建UC发展的预测模型.
- 评估UC的预测模型的性能.
主要方法:
- 基于人口的大型队列 (>83,000个人) 的分析.
- 对42名被诊断患有UC的个人与匹配的健康对照进行了比较.
- 测量血清抗整合素αvβ6抗体 (anti-αvβ6) 和抗内皮蛋白C受体抗体 (anti-EPCR) 标位,以及生活方式和饮食习惯.
主要成果:
- 抗EPCR显示出高预测性表现 (AUC 0.89),与抗αvβ6 (AUC 0.79) 相比.
- 结合的抗EPCR和抗αvβ6模型显示出增强的预测准确性 (AUC 0.92).
- 失眠与临床前UC显著相关 (aOR=2.14).
结论:
- 抗EPCR和抗αvβ6抗体是UC发病的强有力的预测因素.
- 使用抗EPCR和抗αvβ6的组合模型提供了卓越的预测性能.
- 这项研究建立了一种用于预测UC发展的新方法.
更多相关视频
04:15Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
07:32An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Ulcerative Colitis in IBD
